Scholar Rock Holding (FRA:2QK) Institutional Ownership: 73.08% (As of Aug. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:2QK Scholar Rock Holding Corp FRA:2QK
26 GF Score
Price €42.47
! 4 Warning Signs
View Full Analysis

What is Scholar Rock Holding Institutional Ownership?

Scholar Rock Holding FRA:2QK -0.21% 26 Institutional Ownership is 73.08% as of Aug. 02, 2026. GuruFocus rates FRA:2QK with a GF Score™ of 26/100. The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Scholar Rock Holding's institutional ownership is 73.08%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Scholar Rock Holding's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Scholar Rock Holding's Float Percentage Of Total Shares Outstanding is 79.79%.

Scholar Rock Holding Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Scholar Rock Holding's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scholar Rock Holding Institutional Ownership Chart

Scholar Rock Holding Historical Data

The historical data trend for Scholar Rock Holding can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 67.34 67.01 66.66 67.90 68.49 64.74 66.19 66.58 67.37 73.08
FRA:2QK
26GF Score
Scholar Rock Holding Corp FRA:2QK
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Scholar Rock Holding Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 73.08% mean?
Scholar Rock Holding (FRA:2QK) has a Institutional Ownership of 73.08% as of Aug. 02, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Scholar Rock Holding and its competitors.
Is Scholar Rock Holding's Institutional Ownership too high?
Scholar Rock Holding's current Institutional Ownership is 73.08%. Overall, Scholar Rock Holding has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Scholar Rock Holding's Institutional Ownership compare to DFTX and DNTH?
Scholar Rock Holding's Institutional Ownership of 73.08% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Scholar Rock Holding and its competitors. Scholar Rock Holding's current Institutional Ownership is 73.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scholar Rock Holding stock overvalued right now?
Scholar Rock Holding (FRA:2QK) has a current Institutional Ownership of 73.08%. The current Institutional Ownership is 73.08%. Scholar Rock Holding's overall GF Score™ is 26/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Scholar Rock Holding (FRA:2QK), the current Institutional Ownership is 73.08% as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Scholar Rock Holding Business Description

Other Exchanges SRRK:USA2QK:Germany
Address 301 Binney Street, 3rd Floor, Cambridge, MA, USA, 02142
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
26GF Score

Get the complete analysis for FRA:2QK

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€42.47
Price